Vienna Ludovini
About
Vienna Ludovini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology.
According to data from OpenAlex, Vienna Ludovini has authored 102 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 55 papers in Oncology and 41 papers in Molecular Biology. Recurrent topics in Vienna Ludovini's work include Lung Cancer Treatments and Mutations (55 papers), Cancer Genomics and Diagnostics (20 papers) and Colorectal Cancer Treatments and Studies (15 papers). Vienna Ludovini is often cited by papers focused on Lung Cancer Treatments and Mutations (55 papers), Cancer Genomics and Diagnostics (20 papers) and Colorectal Cancer Treatments and Studies (15 papers). Vienna Ludovini collaborates with scholars based in Italy, United States and Malaysia. Vienna Ludovini's co-authors include Lucio Crinò, Rita Chiari, Lorenza Pistola, Guido Bellezza, Vanesa Gregorc, Angelo Sidoni, Federico Cappuzzo, Francesca Romana Tofanetti, Elisa Rossi and Giulio Metro and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.
In The Last Decade
Vienna Ludovini
101 papers receiving 3.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Vienna Ludovini Italy | 33 | 2.1k | 2.0k | 1.3k | 900 | 256 | 102 | 3.5k | ||
| Xiuning Le United States | 32 | 1.8k 0.9× | 2.0k 1.0× | 1.3k 1.0× | 619 0.7× | 255 1.0× | 168 | 3.5k | ||
| Tina Cascone United States | 30 | 1.8k 0.9× | 1.6k 0.8× | 1.4k 1.0× | 684 0.8× | 199 0.8× | 104 | 3.4k | ||
| Ernest Nadal Spain | 34 | 1.8k 0.8× | 1.8k 0.9× | 1.5k 1.1× | 815 0.9× | 228 0.9× | 169 | 3.6k | ||
| Simon Ekman Sweden | 25 | 2.2k 1.0× | 2.5k 1.3× | 1.4k 1.0× | 1.0k 1.1× | 212 0.8× | 116 | 4.2k | ||
| Kazunori Tsukuda Japan | 34 | 1.5k 0.7× | 1.5k 0.8× | 2.1k 1.6× | 1.0k 1.1× | 274 1.1× | 121 | 3.7k | ||
| Christina S. Baik United States | 27 | 2.1k 1.0× | 1.8k 0.9× | 1.3k 1.0× | 685 0.8× | 403 1.6× | 116 | 3.5k | ||
| L. Rhoda Molife United Kingdom | 25 | 1.3k 0.6× | 1.5k 0.8× | 1.3k 1.0× | 680 0.8× | 144 0.6× | 73 | 3.0k | ||
| Ken A. Olaussen France | 29 | 1.7k 0.8× | 1.5k 0.8× | 1.8k 1.4× | 835 0.9× | 356 1.4× | 55 | 3.7k | ||
| Mario Giuliano Italy | 34 | 2.4k 1.2× | 1.2k 0.6× | 1.0k 0.8× | 1.4k 1.6× | 239 0.9× | 109 | 3.8k | ||
| Noriko Yanagitani Japan | 37 | 1.9k 0.9× | 2.0k 1.0× | 1.9k 1.4× | 833 0.9× | 278 1.1× | 171 | 4.3k |
Countries citing papers authored by Vienna Ludovini
Since
Specialization
Citations
This map shows the geographic impact of Vienna Ludovini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vienna Ludovini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vienna Ludovini more than expected).
Fields of papers citing papers by Vienna Ludovini
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Vienna Ludovini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vienna Ludovini. The network helps show where Vienna Ludovini may publish in the future.
Co-authorship network of co-authors of Vienna Ludovini
This figure shows the co-authorship network connecting the top 25 collaborators of Vienna Ludovini. A scholar is included among the top collaborators of Vienna Ludovini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vienna Ludovini. Vienna Ludovini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Rossi, Elisabetta, Michele Aieta, Alfredo Tartarone, et al.. (2021). A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients. Translational Lung Cancer Research. 10(1). 80–92.
2.
Genova, Carlo, Simona Coco, Giovanni Rossi, et al.. (2020). 1277P An exosomal miRNA signature as predictor of benefit from immune checkpoint inhibitors in non-small cell lung cancer. Annals of Oncology. 31. S825–S826.
3.
Ludovini, Vienna, Biagio Ricciuti, Francesca Romana Tofanetti, et al.. (2018). KRAS mutation and DNA repair and synthesis genes in non‑small‑cell lung cancer. Molecular and Clinical Oncology. 9(6). 689–696.
4.
Mandarano, Martina, Guido Bellezza, Maria Laura Belladonna, et al.. (2018). Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 474(2). 159–168.
5.
Ricciuti, Biagio, Andrea De Giglio, Marta Brambilla, et al.. (2018). Immune-related adverse events to predict survival in patients with advanced non-small cell lung cancer treated with nivolumab: A multicenter analysis.. Journal of Clinical Oncology. 36(15_suppl). 9084–9084.
6.
Canale, Matteo, Elisabetta Petracci, Angelo Delmonte, et al.. (2016). Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors. Clinical Cancer Research. 23(9). 2195–2202.
7.
Penzo, Marianna, Vienna Ludovini, Davide Treré, et al.. (2015). Dyskerin and TERC expression may condition survival in lung cancer patients. Oncotarget. 6(25). 21755–21760.
8.
D’Incecco, Armida, Mariacarla Andreozzi, Vienna Ludovini, et al.. (2014). PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients. British Journal of Cancer. 112(1). 95–102.
9.
Ludovini, Vienna, Antonella Flacco, Fortunato Bianconi, et al.. (2013). Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients. Cancer Chemotherapy and Pharmacology. 71(3). 671–680.
10.
Bianconi, Fortunato, Elisa Baldelli, Vienna Ludovini, et al.. (2013). Robustness of complex feedback systems: application to oncological biochemical networks. International Journal of Control. 86(7). 1304–1321.
11.
Ludovini, Vienna, Fortunato Bianconi, Lorenza Pistola, et al.. (2011). Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(4). 707–715.
12.
Marchetti, Andrew A., Carmine Pinto, Gianluigi Taddei, et al.. (2011). KRAS mutations in colorectal cancer patients in Italy: Results from the KRAS aKtive program.. Journal of Clinical Oncology. 29(15_suppl). e14000–e14000.
13.
Bracarda, Sergio, Vienna Ludovini, Camillo Porta, et al.. (2010). Serum thrombospondin-1 (TSP-1), vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2), and basic-fibroblast growth factor (b-FGF) as predictive factors for sorafenib plus interferon-alfa-2a (IFN) in metastatic renal cell carcinoma (MRCC): Biologic results from the randomized phase II RAPSODY trial.. Journal of Clinical Oncology. 28(15_suppl). 4628–4628.
14.
Ludovini, Vienna, Guido Bellezza, Lorenza Pistola, et al.. (2009). High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients. Annals of Oncology. 20(5). 842–849.
15.
Ludovini, Vienna, Stefania Gori, Mariantonietta Colozza, et al.. (2008). Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival. Annals of Oncology. 19(5). 883–890.
16.
Ludovini, Vienna, Lorenza Pistola, Vanesa Gregorc, et al.. (2008). Biological Markers and DNA Flow Cytometric Analysis in Radically Resected Patients with Non-Small Cell Lung Cancer. A Study of the Perugia Multidisciplinary Team for Thoracic Tumors. Tumori Journal. 94(3). 398–405.
17.
Gregorc, Vanesa, Manuel Hidalgo, Anna Spreafico, et al.. (2007). Germline Polymorphisms in EGFR and Survival in Patients With Lung Cancer Receiving Gefitinib. Clinical Pharmacology & Therapeutics. 83(3). 477–484.
18.
Gregorc, Vanesa, Giovanni Luca Ceresoli, Irene Floriani, et al.. (2004). Effects of Gefitinib on Serum Epidermal Growth Factor Receptor and HER2 in Patients with Advanced Non-Small Cell Lung Cancer. Clinical Cancer Research. 10(18). 6006–6012.
19.
Gregorc, Vanesa, Vienna Ludovini, Lorenza Pistola, et al.. (2002). Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Lung Cancer. 39(1). 41–48.
20.
Bellezza, Guido, Angelo Sidoni, E Bucciarelli, et al.. (2000). Biological prognostic factors for early stage completely resected non-small cell lung cancer. Lung Cancer. 29(1). 133–133.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Xiuning Le Breakdown of academic impact, for papers by Tina Cascone Breakdown of academic impact, for papers by Ernest Nadal Breakdown of academic impact, for papers by Simon Ekman Breakdown of academic impact, for papers by Kazunori Tsukuda Breakdown of academic impact, for papers by Christina S. Baik Breakdown of academic impact, for papers by L. Rhoda Molife Breakdown of academic impact, for papers by Ken A. Olaussen Breakdown of academic impact, for papers by Mario Giuliano Breakdown of academic impact, for papers by Noriko Yanagitani